Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs. Yamamoto T, Imai N, Yamamoto K, Ito T, et al. Anticancer Res 2021;41:2569-2573.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yamamoto T, Imai N, Yamamoto K, Ito T, et al. Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs. Anticancer Res 2021;41:2569-2573.
PMID: 33952485